Literature DB >> 11415438

Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression.

S R Hawtin1, A R Davies, G Matthews, M Wheatley.   

Abstract

Most of the large family of G-protein-coupled receptors (GPCRs) possess putative N-glycosylation sites within their N-termini. However, for the vast majority of GPCRs, it has not been determined which, if any, of the consensus glycosylation sites are actually utilized or what the functional ramifications are of modification by oligosaccharide. The occurrence and function of glycosylation of the V(1a) vasopressin receptor (V(1a)R) has been investigated in this study. Using a combination of translation systems that are either glycosylation-competent or do not support glycosylation, we established that of the four putative N-glycosylation sites at Asn(14), Asn(27), Asn(198) and Asn(333) only the first three sites are actually modified by carbohydrate. This was confirmed by disruption of consensus sites by site-directed mutagenesis, individually and in combination. The V(1a)R is not O-glycosylated. The functionality of a series of glycosylation-defective V(1a)R constructs was characterized after expression in HEK 293T cells. It was found that carbohydrate moieties are not required for the receptor to bind any of the four classes of ligand available, or for intracellular signalling. The glycosylation status of the V(1a)R did, however, regulate the level of total receptor expression and also the abundance of receptor at the cell surface. Furthermore, the nature of this regulation (increased or decreased expression) was dictated by the locus of the oligosaccharide modification. Modification of any one of the consensus sites alone, however, was sufficient for wild-type expression, indicating a redundancy within the glycosylation sites. A role for the carbohydrate in the correct folding or stabilization of the V(1a)R is indicated. Glycosylation is not required, however, for efficient trafficking of the receptor to the cell surface. This study establishes the functional importance of N-glycosylation of the V(1a)R.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415438      PMCID: PMC1221930          DOI: 10.1042/0264-6021:3570073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Understanding neurotransmitter receptors: molecular biology-based strategies.

Authors:  M Wheatley
Journal:  Essays Biochem       Date:  1998       Impact factor: 8.000

2.  Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.

Authors:  S R Hawtin; H C Howard; M Wheatley
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

Review 3.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin.

Authors:  R H Michell; C J Kirk; M M Billah
Journal:  Biochem Soc Trans       Date:  1979-10       Impact factor: 5.407

5.  Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA.

Authors:  R J Jackson; T Hunt
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  O-Glycosylation of the V2 vasopressin receptor.

Authors:  H Sadeghi; M Birnbaumer
Journal:  Glycobiology       Date:  1999-07       Impact factor: 4.313

8.  Structure and sequence of the mouse V1a and V1b vasopressin receptor genes.

Authors:  S Kikuchi; A Tanoue; N Goda; N Matsuo; G Tsujimoto
Journal:  Jpn J Pharmacol       Date:  1999-12

9.  The role of N-terminal glycosylation in the human oxytocin receptor.

Authors:  T Kimura; Y Makino; R Bathgate; R Ivell; T Nobunaga; Y Kubota; I Kumazawa; F Saji; Y Murata; T Nishihara; M Hashimoto; M Kinoshita
Journal:  Mol Hum Reprod       Date:  1997-11       Impact factor: 4.025

10.  Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.

Authors:  S R Hawtin; V J Wesley; R A Parslow; S Patel; M Wheatley
Journal:  Biochemistry       Date:  2000-11-07       Impact factor: 3.162

View more
  11 in total

1.  Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Authors:  Raymond L Konger; Glynis A Scott; Yvonne Landt; Jack H Ladenson; Alice P Pentland
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Sputa nerve growth factor forms a preferable substitute to mouse 7S-beta nerve growth factor.

Authors:  Dawn C-I Koh; A Armugam; K Jeyaseelan
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 3.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Probing the Arabidopsis flagellin receptor: FLS2-FLS2 association and the contributions of specific domains to signaling function.

Authors:  Wenxian Sun; Yangrong Cao; Kristin Jansen Labby; Pascal Bittel; Thomas Boller; Andrew F Bent
Journal:  Plant Cell       Date:  2012-03-02       Impact factor: 11.277

5.  A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.

Authors:  Peng Huang; Chongguang Chen; Stephen D Mague; Julie A Blendy; Lee-Yuan Liu-Chen
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

6.  N-Glycan-dependent and -independent quality control of human δ opioid receptor N-terminal variants.

Authors:  Jarkko J Lackman; Piia M H Markkanen; Mireille Hogue; Michel Bouvier; Ulla E Petäjä-Repo
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

7.  Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Authors:  Ning Zhao; Stephanie O Peacock; Chen Hao Lo; Laine M Heidman; Meghan A Rice; Cale D Fahrenholtz; Ann M Greene; Fiorella Magani; Valeria A Copello; Maria Julia Martinez; Yushan Zhang; Yehia Daaka; Conor C Lynch; Kerry L Burnstein
Journal:  Sci Transl Med       Date:  2019-06-26       Impact factor: 17.956

Review 8.  Time-Restricted G-Protein Signaling Pathways via GPR176, Gz, and RGS16 Set the Pace of the Master Circadian Clock in the Suprachiasmatic Nucleus.

Authors:  Shumpei Nakagawa; Khanh Tien Nguyen Pham; Xinyan Shao; Masao Doi
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

9.  High variability and non-neutral evolution of the mammalian avpr1a gene.

Authors:  Sabine Fink; Laurent Excoffier; Gerald Heckel
Journal:  BMC Evol Biol       Date:  2007-09-27       Impact factor: 3.260

10.  Mechanisms underlying the increased plasma ACTH levels in chronic psychosocially stressed male mice.

Authors:  Andrea M Füchsl; Dominik Langgartner; Stefan O Reber
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.